Abstract:Challenges in effectively removing protein-bound uremic toxins (PBUTs), are a significant concern for patients with end stage renal disease (ESRD) undergoing hemodialysis (HD). Conventional 4-hour HD treatments rely on the transport of small and middle molecules through the semipermeable membranes of the hemodialyzer, moving from the blood side to the dialysate compartment. PBUTs, however, circulate bound to human serum albumin (HSA), forming large toxin-protein complexes that cannot cross these membranes. In recent years, the use of pharmaceutical drugs with competitive binding properties has emerged as a promising solution. A 2019 clinical trial demonstrated the potential of enhancing indoxyl sulfate (IS) removal – a key PBUT − by injecting 800 mg of ibuprofen (IBU) over 19 min during the initial phase of HD.Although this increased IS clearance by 2.4-fold, the effect diminished rapidly, returning to pre-infusion levels between 60 and 240 min. Additionally, residual IBU was detected in patients, raising safety concerns and highlighting the unsustainability of this approach.In response, we developed a method for the slow, controlled release of lower doses of IBU throughout the entire HD session using polymeric nanocarriers known for their high drug-loading capacity and controlled release properties. A lab-scale extracorporeal blood circulation circuit was constructed, where IBU (<8 mg) was gradually released into the blood plasma line using fourth-generation polyurea dendrimers (IBU@PURE G4 ). The concentration of free IS was monitored over a 4-hour period, and a membrane module that retains HSA while permeating unbound IS was positioned downstream from the IBU@PURE G4 release site. Our results showed a 3.7-fold increase in the unbound IS concentration in blood plasma and a 3.8-fold increase in IS clearance, validating the displacement effect of controlled low-dose IBU release. This innovative approach not only improves the efficiency of PBUT removal but also reduces the risk of excessive accumulation of competitive binders, such as IBU, in patients undergoing regular HD, making it a safer long-term solution for ESRD management.

Ibuprofen-Immobilized Thin Films: A Novel Approach to Improve the Clearance of Protein-Bound Uremic Toxins

Enhanced protein-bound uremic toxin clearance by a membrane-drug-dendrimer synergic system

Reticular Access to Triptycene-Based Cationic Metal–organic Frameworks for Protein-Bound Uremic Toxins Sorption

A Review of Protein-Bound Uremic Toxin Clearance Strategies in Chronic Kidney Disease

Improved Dialysis Removal of Protein-Bound Uraemic Toxins with a Combined Displacement and Adsorption Technique

Improved dialytic removal of protein-bound uremic toxins by intravenous lipid emulsion in chronic kidney disease rats

Rationale for a New Classification of Solutes of Interest in Chronic Kidney Disease and Hemodialysis

P1101A Bifunctional Adsorber Particle For The Removal Of Hydrophobic Uremic Toxins From Whole Blood Of Renal Failure Patients

Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance

A Bifunctional Adsorber Particle for the Removal of Hydrophobic Uremic Toxins from Whole Blood of Renal Failure Patients

Designing adsorptive membranes for removing protein-bound uremic toxins via π-π and cation-π interaction

Improving the Clearance of Protein-Bound Uremic Toxins Using Cationic Liposomes As an Adsorbent in Dialysate.

Polyethyleneimine-anchored liposomes as scavengers for improving the efficiency of protein-bound uremic toxin clearance during dialysis

Clearance of Protein-Bound Uremic Toxins Using Anion Nanotraps with Record High Uptake

Molecular docking study of biocompatible enzyme interactions for removal of indoxyl sulfate (IS), indole-3-acetic acid (IAA), and p-cresyl sulfate (PCS) protein bound uremic toxins

Adsorption capacity of poly(ether imide) microparticles to uremic toxins

Increasing the Removal of Protein-Bound Uremic Toxins by Liposome-Supported Hemodialysis.

In vitro Removal of Protein-Bound Retention Solutes by Extracorporeal Blood Purification Procedures

Effect of Ionic Strength, pH and Chemical Displacers on the Percentage Protein Binding of Protein-Bound Uremic Toxins

Zwitterionic Polymers As High-Performance Coatings for Hemoperfusion Adsorbents and Their Chemisorption of Protein-Bound Toxins Through Computational Simulations

Structure-based discovery of a new type of scaffold compound as binding competitors for protein-bound Uremic Toxins